IL6 and neuropathy: A small-sized multicentre phase II trial reported a shift in the T helper type 1 (Th1)/ T helper type 2 (Th2) cytokine balance towards Th2 dominance with elevated levels of interleukin-6 (IL-6) in the peripheral blood of patients who developed a painful neuropathy during treatment with bortezomib [95].